Ajay joined our team as a content writer after earning his master's degree. He has been writing for since his graduation as a freelancer and raises voice for the people in need with his work. He likes to work on data-driven news reports. When he is not writing, he spends his time with his family.
Covishield Vs Covaxin, see how theyr are administered, benefits and other information
Everyone in India over the age of 18 years can now get vaccinated from 1st May 2021
As of now, Covishield and Covaxin are the two vaccines that will be administered in India
All the citizens of India who are 18 years old or above can now get themselves vaccinated for COVID-19 from the 1st of May after the government made the announcement earlier this month while it also allowed sales of vaccines to private players which are Covishield and Covaxin. We are going to talk about Covaxin Vs Covisheid and look at the benefits they offer, the probable side-effects and many other info.
The registration process on the government’s CoWin platform already began yesterday i.e. on 28th April. Currently, the government-sponsored drive covers only those over the age of 45 years at designated vaccination sites.
Currently, there are only 2 COVID vaccines – Covishield and Covaxin – which have been given the green flag to be administered to the citizens of India. Imported, fully ready-to-use foreign vaccines such as Sputnik V, developed by the Gamaleya Research Institute in Russia, will also become available in the open market later.
All those who are between the age of 18 and 45 will have the option to buy their vaccines once private sales starts or states buy stocks to vaccinate them. While prices for the end users have yet to be announced, in the central government hospitals, all vaccinations will still remain free for people.
There are some states who have made announcements about providing the vaccination for free.
Let us see the detailed comparison between Covaxin and Covisheild
1. Covaxin Vs Covishield: Developer
Covishield
Covaxin
Covishield is the vaccine of the Oxford- AstraZeneca
Covaxin is an indigenous COVID vaccine developed by Bharat Biotech as well as the Indian clinical research body Indian Council of Medical Research (ICMR).
Covishield is being manufactured by the Serum Institute of India.
Covaxin uses the dead Cornavirus prompting the immune system of the body to make antibodies against Coronavirus, as per BBC report.
The BBC said it is “made from a weakened version of a common cold virus (known as an adenovirus) from chimpanzees. It has been modified to look more like coronavirus – although it can’t cause illness,”
2. Covaxin Vs Covishield: How They Work
Covishield
Covaxin
Covishield, on the other hand, once injected into a person’s arm, bump into cells and latch onto proteins on their surface as per NYTimes.
Once delivered, the Covaxin teaches the immune system of the body to produce antibodies against the SARS-CoV-2 coronavirus according to the report from New York Times
“The cell engulfs the virus in a bubble and pulls it inside. Once inside, the adenovirus escapes from the bubble and travels to the nucleus, the chamber where the cell’s DNA is stored,” it said.
NTY also added, “The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface”.
3. Covaxin Vs Covishield: Efficacy
Covishield
Covaxin
Covisheild has an efficacy of 70%
Covaxin has shown an efficacy rate of 78% in its second interim analysis
However, Covishield’s efficacy could be more than 90% when it is administered as a half dose followed by a full dose one month later.
However, Covaxin has shown 100% against the “severe COVID-19 patients”.
4. Covaxin Vs Covishield: Storage Requirements
Covishield
Covaxin
Covishield can be stored in temperatures between 2°C and 8 °C.
Covaxin can be stored in temperatures between 2°C and 8 °C.
5. Covaxin Vs Covishield: Probable Side-effects
Covishield
Covaxin
Pain and tenderness at the site of injection site
Pain and swelling at the site of the injection
Headache
Headache
Fatigue
Fatigue
Myalgia (muscle pain)
Fever
Malaise (Generalised weakness)
Body ache
Pyrexia (fever)
Abdominal pain
Chills
Nausea and vomiting
Arthralgia (joint pain)
Dizziness-giddiness
Nausea
Sweating
Cold and cough
Tremors
Tremors
6. Covaxin Vs Covishield: Possible Price
Covishield
Covaxin
Serum Institute of India offers one dose of Covishield to the Central Government for ₹ 150 per dose
Central Government procure Covaxin for ₹ 150 per dose
Covishield will cost ₹ 400 per dose to states
Covaxin will cost ₹ 600 per dose to the states
Covishield will cost ₹ 600 per dose to private hospitals
Covaxin will cost ₹ 1,200 per dose for private hospitals
7. Covaxin Vs Covishield: Gap Between First And Second Dose
Covishield
Covaxin
The second dose of Covishield can be administered after 6 to 8 weeks from the first dose
The second dose of Covaxin can be administered after 4 to 6 weeks from the first dose
